Tricida Inc (TCDA) |
|
4.52 -0.2 (-4.24%)
|
03-05 09:13 |
|
Open: |
4.6 |
Pre. Close: |
4.72 |
|
High:
|
4.68 |
Low:
|
4.29 |
|
Volume:
|
1,174,817 |
Market Cap:
|
227M |
|
|
|
|
Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). The company has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.689 - 4.716 |
4.716 - 4.745 |
|
Low:
|
4.22 - 4.248 |
4.248 - 4.278 |
|
Close:
|
4.465 - 4.516 |
4.516 - 4.57 |
|
Technical analysis |
as of: 2021-03-05 8:52:51 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 7.80  One year: 9.53 |
| Support: |
Support1: 4.29 Support2: 3.57 |
| Resistance: |
Resistance1: 6.68 Resistance2: 8.16 |
| Pivot: |
6.28 |
| Moving Average: |
MA(5): 4.83 MA(20): 6.52
MA(100): 7.24 MA(250): 15.33 |
| MACD: |
MACD(12,26): -0.58 Signal(9): -0.31 |
| Stochastic oscillator: |
%K(14,3): 4.39  %D(3): 4.04 |
| RSI: |
RSI(14): 28.78 |
| 52-week: |
High: 32.99 Low: 3.74 Change(%): -86.2 |
| Average Vol(K): |
3-Month: 92273 10-Days: 160994 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.TCDA has closed above bottom band by 8.5%. Bollinger Bands are 134.7% wider than normal. The large width of the bands suggest high volatility as compared to TCDA's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 04 Mar 2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tricida, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2021 - TCDA - Yahoo Finance
Thu, 04 Mar 2021
Should You Hold Tricida Inc (TCDA) in Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver
Wed, 03 Mar 2021
TCDA FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Tricida Inc. Investors to Secure Counsel Before Important Monday Deadline - TCDA - Yahoo Finance
Wed, 03 Mar 2021
Should Drug Manufacturers - Specialty & Generic Stock Tricida Inc (TCDA) Be in Your Portfolio Wednesday? - InvestorsObserver
Wed, 03 Mar 2021
Tricida Granted Additional U.S. Patent Covering Composition of Matter of Veverimer - GlobeNewswire
Tue, 02 Mar 2021
Tricida, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
50 |
| Shares Float (M) |
27 |
|
% Held by Insiders
|
2.74 |
|
% Held by Institutions
|
91.62 |
|
Shares Short (K)
|
4,620 |
|
Shares Short P. Month (K)
|
4,260 |
Stock Financials |
|
EPS
|
-5.370 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
3.200 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-41.8 |
|
Return on Equity (ttm)
|
-113.5 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-5.172 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-219 |
|
Levered Free Cash Flow (M)
|
-123 |
Stock Valuations |
|
PE Ratio
|
-0.84 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.41 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-1.04 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
